Developability index: a rapid in silico tool for the screening of antibody aggregation propensity.

Determining the aggregation propensity of protein-based biotherapeutics is an important step in the drug development process. Typically, a great deal of data collected over a large period of time is needed to estimate the aggregation propensity of biotherapeutics. Thus, candidates cannot be screened early on for aggregation propensity, but early screening is desirable to help streamline drug development. Here, we present a simple molecular computational method to predict the aggregation propensity via hydrophobic interactions, thought to be the most common mechanism of aggregation, and electrostatic interactions. This method uses a new quantity termed Developability Index. It is a function of an antibody's net charge, calculated on the full-length antibody structure, and the spatial aggregation propensity, calculated on the complementarity-determining region structure. Its accuracy is due to the molecular level details and the incorporation of the tertiary structure of the antibody. It is particularly applicable to antibodies or other proteins for which structures are available or could be determined accurately using homology modeling. Applications include the selection of molecules in the discovery or early development process, selection of mutants for stability, and estimation of resources needed for development of a given biomolecule.

[1]  J. Deisenhofer.  Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. , 1981, Biochemistry.

[2]  A R Rees,et al.  WAM: an improved algorithm for modelling antibodies on the WEB. , 2000, Protein engineering.

[3]  M. Kerr,et al.  Semi-extended solution structure of human myeloma immunoglobulin D determined by constrained X-ray scattering. , 2005, Journal of molecular biology.

[4]  Naresh Chennamsetty,et al.  Design and application of antibody cysteine variants. , 2010, Bioconjugate chemistry.

[5]  C. Roberts.  Kinetics of Irreversible Protein Aggregation: Analysis of Extended Lumry−Eyring Models and Implications for Predicting Protein Shelf Life , 2003 .

[6]  Garrett M. Morris,et al.  Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design , 2001, Science.

[7]  Bernhardt L Trout,et al.  Aggregation in protein-based biotherapeutics: computational studies and tools to identify aggregation-prone regions. , 2011, Journal of pharmaceutical sciences.

[8]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[9]  I. Correia,et al.  Stability of IgG isotypes in serum , 2010, mAbs.

[10]  Jeffrey J. Gray,et al.  Toward high‐resolution homology modeling of antibody Fv regions and application to antibody–antigen docking , 2009, Proteins.

[11]  Bernhardt L Trout,et al.  Aggregation-prone motifs in human immunoglobulin G. , 2009, Journal of molecular biology.

[12]  Naresh Chennamsetty,et al.  Predictive tools for stabilization of therapeutic proteins , 2009, mAbs.

[13]  R. Borchardt,et al.  Stability of Protein Pharmaceuticals , 1989, Pharmaceutical Research.

[14]  Sandeep Kumar,et al.  Potential Aggregation-Prone Regions in Complementarity-Determining Regions of Antibodies and Their Contribution Towards Antigen Recognition: A Computational Analysis , 2010, Pharmaceutical Research.

[15]  Saurabh Aggarwal,et al.  What's fueling the biotech engine—2007 , 2008, Nature Biotechnology.

[16]  D. Mould,et al.  Development of hydrophobicity parameters to analyze proteins which bear post- or cotranslational modifications. , 1991, Analytical biochemistry.

[17]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[18]  Paolo Marcatili,et al.  PIGS: automatic prediction of antibody structures , 2008, Bioinform..

[19]  Heather Franey,et al.  Increased aggregation propensity of IgG2 subclass over IgG1: Role of conformational changes and covalent character in isolated aggregates , 2010, Protein science : a publication of the Protein Society.

[20]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[21]  A. Rosenberg,et al.  Effects of protein aggregates: An immunologic perspective , 2006, The AAPS Journal.

[22]  Jan H. Jensen,et al.  Very fast prediction and rationalization of pKa values for protein–ligand complexes , 2008, Proteins.

[23]  Jan H. Jensen,et al.  Very fast empirical prediction and rationalization of protein pKa values , 2005, Proteins.

[24]  Eiji Sawa,et al.  Influence of pH on heat-induced aggregation and degradation of therapeutic monoclonal antibodies. , 2010, Biological & pharmaceutical bulletin.

[25]  M. Vendruscolo,et al.  The Zyggregator method for predicting protein aggregation propensities. , 2008, Chemical Society reviews.

[26]  Brian M. Murphy,et al.  Stability of Protein Pharmaceuticals: An Update , 2010, Pharmaceutical Research.

[27]  Karsten Mäder,et al.  Assessment of net charge and protein-protein interactions of different monoclonal antibodies. , 2011, Journal of pharmaceutical sciences.

[28]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[29]  Bernhardt L. Trout,et al.  Design of therapeutic proteins with enhanced stability , 2009, Proceedings of the National Academy of Sciences.

[30]  M. Taussig,et al.  Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody—antigen interaction , 1997, Nature Structural Biology.

[31]  D. Kalonia,et al.  Long- and Short-Range Electrostatic Interactions Affect the Rheology of Highly Concentrated Antibody Solutions , 2009, Pharmaceutical Research.

[32]  L. Serrano,et al.  Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins , 2004, Nature Biotechnology.

[33]  Bernhardt L Trout,et al.  Prediction of aggregation prone regions of therapeutic proteins. , 2010, The journal of physical chemistry. B.

[34]  B. Nilsson,et al.  The effect of increasing hydrophobicity on the self-assembly of amphipathic beta-sheet peptides. , 2009, Molecular bioSystems.

[35]  Hollis Lau,et al.  Acid-induced aggregation of human monoclonal IgG1 and IgG2: molecular mechanism and the effect of solution composition. , 2010, Biochemistry.